nonpolar
cell
cultur
model
influenza
viru
shown
enter
host
cell
via
multipl
endocyt
pathway
includ
classic
clathrinmedi
endocyt
rout
cme
clathrinand
caveolaeindepend
rout
macropinocytosi
howev
littl
known
entri
rout
influenza
viru
differenti
epithelia
vivo
site
infect
influenza
viru
show
polar
madindarbi
canin
kidney
type
ii
mdck
ii
cell
influenza
viru
specif
util
clathrinmedi
endocyt
pathway
requir
host
cell
entri
anim
virus
take
advantag
divers
cellular
endocyt
pathway
gain
access
host
cell
viru
bind
host
cell
receptor
endocytos
virus
initi
replic
penetr
fuse
endosom
membran
role
dynamindepend
endocytosi
influenza
viru
entri
first
demonstr
examin
effect
dominantneg
dn
dynamin
small
gtpase
mediat
scission
clathrinco
vesicl
plasma
membran
influenza
viru
entri
lung
cell
studi
group
also
show
infect
influenza
virus
cell
express
dn
mutant
epiderm
growth
factor
receptor
pathway
substrat
inhibit
clathrindepend
endocytosi
specif
impair
hela
cell
chemic
inhibitor
well
dn
mutant
use
disrupt
caveolaedepend
endocytosi
host
cell
influenza
infect
retain
compar
untreat
cell
observ
led
realiz
nonclathrindepend
noncaveolaedepend
endocyt
pathway
exist
influenza
viru
entri
addit
classic
clathrindepend
pathway
recent
detail
dissect
influenza
entri
pathway
independ
dynamin
use
pharmacolog
inhibitor
de
vri
et
al
discov
influenza
viru
util
macropinocytosislik
rout
mani
cell
type
recent
advanc
live
cell
imag
individu
influenza
particl
track
real
time
without
disrupt
endocyt
pathway
novel
techniqu
discov
redund
parallel
endocyt
pathway
new
techniqu
adaptor
protein
interact
clathrin
adaptor
clathrinco
pit
demonstr
influenza
cargospecif
adaptor
entri
via
clathrinmedi
endocyt
cme
pathway
cell
examin
dynam
endocyt
uptak
also
led
conclus
influenza
virus
exploit
differ
pathway
effici
nonclass
lesscharacter
pathway
act
altern
pathway
influenza
viru
entri
polar
simpl
epitheli
cell
plasma
membran
separ
tight
junction
two
clearli
distinct
domain
apic
domain
face
tract
lumen
basolater
surfac
face
extracellular
matrix
cellular
actin
microtubul
network
well
array
cellular
protein
particip
organ
mainten
cell
polar
well
recogn
influenza
enter
bud
apic
domain
polar
mdck
cell
previou
studi
laboratori
demonstr
actin
microfila
play
differ
role
influenza
viru
infect
polar
epitheli
cell
compar
nonpolar
cell
contrast
dispens
role
viral
infect
nonpolar
cell
intact
actin
filament
obligatori
influenza
viru
infect
polar
epitheli
cell
sinc
signific
differ
polar
nonpolar
cell
regard
receptor
distribut
cytoskelet
structur
traffick
event
mechan
endocytosi
possibl
current
knowledg
influenza
viru
entri
nonpolar
cell
hela
mdck
cell
complet
appli
vivo
viral
infect
initi
differenti
airway
epitheli
cell
examin
influenza
viru
entri
pathway
use
pharmacolog
inhibitor
dn
mutant
protein
fulli
polar
mdck
ii
cell
well
establish
robust
model
differenti
epithelia
prepar
viru
stock
infect
approxim
plaqueform
unit
pfu
influenza
viru
viru
inocul
specificpathogenfre
chicken
embryo
h
post
inocul
allanto
fluid
infect
embryo
collect
clarifi
centrifug
min
use
viru
stock
viru
stock
titer
plaqu
assay
mdbk
bovin
kidney
cell
store
order
obtain
polar
mdck
ii
epitheli
cell
cultur
mdck
ii
cell
provid
dr
colin
parrish
cornel
univers
grown
dmem
media
supplement
fetal
bovin
serum
penicillin
streptomycin
cellgro
lm
semiperm
transwel
filter
corn
polar
monitor
measur
transepitheli
electr
resist
teer
monolay
cultiv
semiperm
filter
use
evomx
meter
along
electrod
cell
cultur
insert
world
precis
instrument
measur
cultur
media
chang
fresh
warm
media
filter
insert
confluent
day
transwel
filter
mdck
ii
reach
averag
teer
ohmscm
consist
observ
literatur
mdck
cell
atcc
polar
display
fibroblastlik
epithelialik
morpholog
use
control
due
inabl
form
tight
monolay
measur
teer
cell
grown
cultur
condit
mdck
ii
cell
transwel
filter
lower
teer
mdck
ii
cell
differ
chemic
inhibitor
list
use
treat
fulli
polar
mdck
ii
cell
nonpolar
mdck
cell
min
infect
influenza
viru
dilut
rpmi
medium
contain
bovin
serum
albumin
sigma
mm
hepe
ph
inhibitortr
cell
incub
influenza
viru
moi
moi
mdck
ii
h
presenc
inhibitor
viru
adsorpt
inoculum
replac
fresh
media
dmem
supplement
fetal
bovin
serum
inhibitor
durat
incub
period
h
post
infect
cell
fix
analyz
chlorpromazin
cpz
dynasor
amilorid
eipa
methylbcyclodextrin
mbcd
nystatin
purchas
sigmaaldrich
wild
type
wt
dn
construct
obtain
dr
mark
mcniven
mayo
clinic
cancer
center
wt
dn
plasmid
receiv
dr
jennif
lippincottschwartz
nih
wt
dn
plasmid
provid
dr
xiaowei
zhuang
harvard
univers
construct
gift
dr
ari
heleniu
eth
cell
seed
glass
cover
slip
transwel
filter
infect
incub
cell
fix
paraformaldehyd
pfa
detect
influenza
infect
use
mous
antinucleoprotein
np
antibodi
atcc
secondari
antibodi
alexafluor
goat
antimous
purchas
molecular
probe
nuclei
stain
hoechst
molecular
probe
cover
slip
cell
mount
glass
slide
use
mowiol
cell
glass
cover
slip
examin
nikon
eclips
fluoresc
microscop
equip
sensicam
em
camera
cook
corp
mdck
ii
cell
transwel
filter
imag
leica
confoc
microscop
mdck
cell
infect
influenza
viru
chemic
treatment
mock
treatment
cell
lyse
ripa
buffer
millipor
proteas
inhibitor
cocktail
roch
lysat
clarifi
centrifug
mix
laemmli
buffer
bmercaptoethanol
western
blot
band
reveal
antibodi
influenza
viru
matrix
protein
atcc
antimous
secondari
antibodi
coupl
horseradish
peroxidas
overcom
difficulti
recombin
protein
express
polar
cell
use
defin
electropor
condit
fulli
polar
mdck
ii
cell
describ
lgml
plasmid
dna
mix
electropor
buffer
eppendorf
deliv
use
electrod
nepagen
connect
ecm
electropor
system
btx
instrument
examin
cme
pathway
polar
mdck
cell
first
util
pharmacolog
inhibitor
target
cme
pathway
host
cell
chlorpromazin
cpz
prevent
clathrin
assembl
wide
use
block
cme
includ
studi
entri
mechan
influenza
virus
nonpolar
cell
dynasor
inhibitori
effect
gtpase
activ
dynamin
low
cell
toxic
sinc
discoveri
dynasor
wide
use
specif
dynamin
inhibitor
entri
studi
variou
viru
cpz
dynasor
use
treat
fulli
polar
mdck
ii
cell
nonpolar
cell
min
infect
influenza
viru
h
post
infect
cell
fix
analyz
immunofluoresc
microscopi
cell
sensit
toxic
cpz
mdck
ii
cell
thu
lower
concentr
cpz
use
treat
cell
quantiti
inhibitor
use
treatment
affect
cell
viabil
data
shown
treatment
cpz
mdck
ii
caus
substanti
reduct
number
np
express
cell
influenza
infect
fig
howev
dynasor
treatment
obviou
impact
polar
mdck
ii
cell
nonpolar
counterpart
fig
evid
indic
potenti
role
dynamin
entri
pathway
polar
mdck
ii
cell
nonpolar
cell
depend
much
dynamin
usag
entri
effect
cpz
dynamin
canin
kidney
cell
confirm
western
blot
analysi
fig
pharmacolog
approach
mention
indic
import
role
cme
influenza
viru
infect
polar
mdck
ii
cell
nonpolar
cell
howev
wish
examin
specif
compon
cme
pathway
convent
transfect
method
cation
lipid
adenoviru
transduct
either
low
transfect
effici
ideal
studi
overcom
difficulti
recombin
protein
express
use
electropor
monolay
cell
describ
electropor
wt
dn
construct
dynamin
fig
fig
fig
fulli
polar
mdck
ii
cell
infect
cell
influenza
viru
moi
h
post
electropor
cell
fix
stain
confoc
microscopi
h
infect
express
dn
form
dynamin
result
statist
signific
reduct
percentag
gfp
eyfp
express
cell
posit
viral
np
express
compar
control
wt
version
respect
construct
fig
unlik
nonpolar
cell
hela
cell
describ
previou
studi
dn
construct
express
mdck
ii
cell
also
significantli
reduc
percentag
cell
infect
influenza
viru
express
viral
np
compar
wt
counterpart
express
cell
recent
influenza
viru
shown
abl
enter
host
cell
via
macropinocytosi
pathway
examin
whether
influenza
viru
also
util
macropinocytosi
polar
mdck
ii
cell
use
amilorid
eipa
macropinocytosi
inhibitor
inhibit
na
h
exchang
activ
treat
canin
kidney
cell
infect
influenza
viru
examin
viral
protein
whole
cell
lysat
use
western
blot
analysi
found
neither
cell
mdck
ii
cell
significantli
inhibit
eipa
compar
lead
control
regardless
drug
treatment
concentr
fig
data
suggest
similar
nonpolar
mdck
cell
exist
redund
entri
pathway
presum
cme
polar
mdck
cell
macropinocytosi
preferenti
major
pathway
util
influenza
viru
cell
use
studi
nonpolar
cell
system
influenza
shown
enter
host
cell
via
caveolaeindepend
entri
rout
examin
whether
influenza
viru
enter
polar
mdck
ii
cell
via
caveolaeindepend
entri
pathway
previou
studi
nonpolar
cell
first
treat
mdck
ii
cell
differ
concentr
caveolaeinhibit
drug
methylbcyclodextrin
mbcd
nystatin
reveal
express
viral
protein
western
blot
treatment
high
concentr
mbcd
abl
inhibit
polar
mdck
ii
cell
nonpolar
cell
fig
contrast
nystatin
inhibitori
effect
either
cell
type
examin
caveolarmedi
pathway
specif
polar
mdck
ii
cell
electropor
gfptag
wt
dn
plasmid
polar
mdck
ii
cell
infect
influenza
viru
major
structur
protein
caveola
use
confoc
microscopi
wt
dn
express
cell
abl
infect
influenza
viru
shown
posit
signal
viral
np
transfect
cell
fig
discrep
influenza
viru
infect
mdck
ii
cell
treatment
mbcd
nystatin
may
due
discret
mode
action
two
drug
mbcd
inhibit
influenza
viru
entri
mdck
ii
cell
inhibit
caveolaedepend
endocytosi
alter
structur
cholesterolrich
domain
plasma
membran
similar
observ
also
describ
sarscoronaviru
entri
studi
taken
togeth
data
demonstr
similar
nonpolar
mdck
cell
influenza
viru
enter
polar
mdck
ii
caveolaedepend
endocytosi
knowledg
first
time
endocyt
pathway
employ
influenza
viru
fulli
polar
epitheli
cell
system
grown
transwel
filter
examin
polar
epitheli
cell
usual
refractori
transfect
difficult
work
compar
nonpolar
cell
compon
cme
pathway
shown
regul
cell
polar
avoid
dn
cellular
protein
disrupt
format
proper
cellular
polar
chose
introduc
dn
construct
mdck
ii
cell
cell
form
tight
monolay
fulli
polar
convent
transfect
method
util
cation
lipid
often
yield
low
transfect
effici
polar
epitheli
cell
data
shown
adenoviru
transduct
introduc
recombin
protein
polar
epithelia
anoth
frequent
use
method
howev
adenoviru
induc
macropinocytosi
undesir
signal
event
gain
access
host
cell
dn
protein
small
reduct
percentag
mdck
ii
cell
infect
influenza
viru
may
due
mask
effect
endocyt
pathway
viru
particl
enter
cme
pathway
inhibit
least
partial
dynamin
dn
protein
unexpectedli
larg
portion
polar
mdck
ii
cell
express
dn
abl
infect
influenza
viru
fig
adaptor
protein
interact
synaptojanin
via
ep
homolog
eh
domain
recruit
cargo
adaptor
protein
plasma
membran
inhibitori
effect
dn
protein
influenza
viru
entri
polar
mdck
ii
cell
suggest
play
import
role
influenza
viru
entri
cme
pathway
requir
function
influenza
viru
clathrinco
pit
could
involv
differ
adaptor
protein
associ
nonpolar
cell
system
well
document
influenza
viru
enter
host
cell
cme
howev
entri
rout
clathrin
caveolaeindepend
rout
macropinocytosi
also
describ
suggest
influenza
infecti
entri
util
differ
endocyt
rout
differ
nonpolar
epitheli
cell
type
use
pharmacolog
molecular
approach
studi
demonstr
influenza
viru
select
enter
polar
mdck
ii
cell
via
clathrindepend
rout
